These authors contributed equally to this work.
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Original Article
You have full text access to this OnlineOpen article
Role of caspase-8 in hepatocyte response to infection and injury in mice†
Article first published online: 23 MAR 2007
DOI: 10.1002/hep.21495
Copyright © 2006 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Ben Moshe, T., Barash, H., Kang, T.-B., Kim, J.-C., Kovalenko, A., Gross, E., Schuchmann, M., Abramovitch, R., Galun, E. and Wallach, D. (2007), Role of caspase-8 in hepatocyte response to infection and injury in mice. Hepatology, 45: 1014–1024. doi: 10.1002/hep.21495
- †
Potential conflict of interest: Nothing to report.
- ‡
These authors contributed equally to this work.
- §
fax: (972) 8-9343165
Publication History
- Issue published online: 28 MAR 2007
- Article first published online: 23 MAR 2007
- Manuscript Accepted: 1 NOV 2006
- Manuscript Received: 30 MAY 2006
Funded by
- Ares Trading SA, Switzerland
- Center of Excellence Grant from the Flight Attendant Medical Research Institute (FAMRI)
- Joseph and Bessie Feinberg Foundation
- Yeshaya Horowitz Association through The Center for Complexity Science
- Israel Science Foundation. Grant Number: 728/05
- Israel Ministry of Science, through a grant given to the National Gene Therapy Knowledge Center and through EC grants. Grant Numbers: LSHB-CT-2004-512034, LSHB-CT-2005-018961
- Blum
- Harold Grinspoon
- Horowitz
- Wolfson Foundations
References
- 1. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9: 459–470.
- 2, , , . Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996; 85: 803–815.
- 3, , , , , , et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85: 817–827.
- 4, , , , , . Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999; 17: 331–367.
- 5, , , , , , et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998; 9: 267–276.
- 6, , , , . Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998; 392: 296–300.
- 7, , , , , . A role for FADD in T cell activation and development. Immunity 1998; 8: 439–449.
- 8, , , , . A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J 1998; 17: 706–718.
- 9, , , . Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med 1999; 190: 1879–1890.
- 10, , , . Caspase activation is required for T cell proliferation. J Exp Med 1999; 190: 1891–1896.
- 11, , , , , , et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002; 419: 395–399.
- 12, , , , , , et al. Ex vivo whole-embryo culture of caspase-8-deficient embryos normalize their aberrant phenotypes in the developing neural tube and heart. Cell Death Differ 2002; 9: 1196–1206.
- 13, , , , , , et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17: 883–895.
- 14, , , , , , et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 2004; 173: 2976–2984.
- 15, , , , , , et al. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 2005; 307: 1465–1468.
- 16, , , , . Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J Immunol 2005; 175: 3469–3473.
- 17, . Listeria monocytogenes: clinical and experimental update. J Infect Dis 2002; 185(Suppl 1): S18–S24.
- 18, , . Liver regeneration. HEPATOLOGY 2006; 43: S45–53.
- 19, , , , , , et al. Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem 2005; 280: 2562–2568.
- 20. Cytokine regulation of liver injury and repair. Immunol Rev 2000; 174: 160–171.
- 21, . Liver regeneration. Science 1997; 276: 60–66.
- 22, , , , , , et al. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet 1995; 11: 294–300.
- 23, , , , . Contribution of the lymphotoxin beta receptor to liver regeneration. J Immunol 2005; 175: 1295–1300.
- 24, , , , . Massive liver growth in mice induced by systemic interleukin 6 administration. HEPATOLOGY 2003; 38: 326–334.
- 25, , , , , , et al. Functional MRI during hypercapnia and hyperoxia: a non-invasive monitoring toll for changes in liver perfusion and hemodynamics in a rat model. Radiology (in press).
- 26, , , , , , et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. HEPATOLOGY 2003; 38: 1188–1198.
- 27, , , . Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 1992; 52: 296–302.
- 28, , , , , . Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats. Am J Physiol 1996; 270: G909–G918.
- 29, , , , , . Gadolinium chloride-induced hepatocyte proliferation is prevented by antibodies to tumor necrosis factor alpha. Toxicol Appl Pharmacol 2001; 170: 39–45.
- 30, , , , , . Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes. Infect Immun 1998; 66: 4143–4150.
- 31, , , , , , et al. MORT1/FADD is involved in liver regeneration. World J Gastroenterol 2005; 11: 7248–7253.
- 32, , , , , . Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration. HEPATOLOGY 1995; 21: 1695–1701.
- 33, , . Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86–89.
- 34, , , , , , et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 2005; 202: 1691–1701.
- 35, , , , . Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma. Biochem Biophys Res Commun 1999; 262: 381–387.
- 36, , , , , , et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000; 6: 529–535.
- 37, , , , , , et al. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Oncogene 2002; 21: 8510–8514.
- 38, , , , , , et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 2003; 125: 708–715.
- 39, , , , , , et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 2005; 65: 815–821.
- 40, , , , , , et al. Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene 2005; 24: 141–147.
- 41, , , , , , et al. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element. Gastroenterology 2005; 129: 1602–1615.
- 42. The metabolic code. Science 1975; 189: 760–763.
- 43, . Cell biology. Kinasing and clipping down the NF-kappa B trail. Science 2005; 308: 65–66.
- 44, . Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004; 117: 561–574.
- 45, , , , , , et al. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 2006; 440: 1064–1068.
- 46, . Origin and evolution of eukaryotic apoptosis: the bacterial connection. Cell Death Differ 2002; 9: 394–404.